[February 03, 2012] Top 5 Companies in the Life Sciences Tools & Services Industry With the Highest Debt to EBITDA Ratio (NGNM, AMRI, TMO, CRL, AFFX) Tweet Feb 03, 2012 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Life Sciences Tools & Services industry with the highest debt to EBITDA ratios. This ratio indicates how many years of EBITDA would be necessary in order to pay back all the debt (assuming Debt and EBITDA are constant). Typically, this ratio is considered to be alarming when it is greater than 3.0 but this can vary and should be looked at within the context of the industry.NeoGenomics ranks highest with a a debt to EBITDA ratio of 12.7. Following is Albany Molecular Research with a a debt to EBITDA ratio of 8.0. Thermo Fisher Scientific ranks third highest with a a debt to EBITDA ratio of 3.3. Charles River Laboratories follows with a a debt to EBITDA ratio of 3.0, and Affymetrix rounds out the top five with a a debt to EBITDA ratio of 2.9. SmarTrend recommended that subscribers consider buying shares of NeoGenomics on October 28th, 2011 as our technology indicated a new Uptrend was in progress when shares hit $1.32. Since that recommendation, shares of NeoGenomics have risen 32.6%. We continue to monitor NeoGenomics for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]